US National Institutes of Health says it has halted a clinical trial to evaluate the safety and effectiveness of the malaria drug hydroxychloroquine for the treatment of hospitalized COVID-19 patients.
The U.S. National Institutes of Health said on Saturday it has halted a clinical trial to evaluate the safety and effectiveness of the malaria drug hydroxychloroquine for the treatment of hospitalized COVID-19 patients.
The U.S. Food and Drug Administration revoked its emergency use authorization for hydroxychloroquine to treat COVID-19 on Monday.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Millions Of Hydroxychloroquine Pills That Trump Touted For COVID-19 Are Now In LimboHealth officials are unsure what to do with stockpiles of the drug and the related chloroquine after the FDA declared them risky and likely ineffective to treat coronavirus.
続きを読む »
Trump acknowledges some people may catch Covid-19 at Tulsa rallyDays before hosting a massive rally in Tulsa, Oklahoma, President Trump said in a Wall Street Journal interview that some people at the rally this Saturday may catch coronavirus, but added “it’s a very small percentage”
続きを読む »
Fox News poll: Biden leads Trump 50-38, COVID-19, racism, major issues - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
続きを読む »
Millions Of Hydroxychloroquine Pills That Trump Touted For COVID-19 Are Now In LimboHealth officials are unsure what to do with stockpiles of the drug and the related chloroquine after the FDA declared them risky and likely ineffective to treat coronavirus.
続きを読む »